GlyCosmos Glycolipids
Glycolipid entries from the LIPID MAPS Structure Database (LMSD).
| Database | Last Updated |
|---|---|
| ChEBI | February 3, 2022 |
| KEGG | February 3, 2022 |
| LIPID MAPS Structure Database | February 3, 2022 |
| LipidBank | February 3, 2022 |
| PubChem | February 3, 2022 |
| Main Class | Sub Class | LM ID | Common Name ▲ | LipidBank ID | KEGG ID | PubChem CID | ChEBI ID | Exact Mass | Formula |
|---|---|---|---|---|---|---|---|---|---|
|
Neutral glycosphingolipids
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
ClcNAc-Lex-5(d18:1/22:0)
|
1659.981127
|
C80H145N3O32
|
|||||
|
Neutral glycosphingolipids
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
ClcNAc-Lex-5(d18:1/24:0)
|
1688.012427
|
C82H149N3O32
|
|||||
|
Neutral glycosphingolipids
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
ClcNAc-Lex-5(d18:1/24:1(15Z))
|
1685.996777
|
C82H147N3O32
|
|||||
|
Neutral glycosphingolipids
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
ClcNAc-Lex-5(d18:1/26:0)
|
1716.043727
|
C84H153N3O32
|
|||||
|
Neutral glycosphingolipids
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
ClcNAc-Lex-5(d18:1/26:1(17Z))
|
1714.028077
|
C84H151N3O32
|
|||||
|
Neutral glycosphingolipids
|
Simple Glc series (GlcCer, LacCer, etc.)
|
Cortenuamide A
|
839.685034
|
C49H93NO9
|
|||||
|
Neutral glycosphingolipids
|
Simple Glc series (GlcCer, LacCer, etc.)
|
Cortenuamide B
|
825.669384
|
C48H91NO9
|
|||||
|
Neutral glycosphingolipids
|
Simple Glc series (GlcCer, LacCer, etc.)
|
Cortenuamide C
|
811.653734
|
C47H89NO9
|
|||||
|
Neutral glycosphingolipids
|
Simple Glc series (GlcCer, LacCer, etc.)
|
Crispin A
|
713.544184
|
C40H75NO9
|
|||||
|
Neutral glycosphingolipids
|
Simple Glc series (GlcCer, LacCer, etc.)
|
Crispin B
|
903.607179
|
C51H85NO12
|
Displaying entries 281 - 290 of 6008 in total
To see the latest features, please visit our beta site.
International Collaboration
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Acknowledgements
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
